Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review Kiran Kumar RathinamJustin Jacob AbrahamPriyadharshini A Review 17 January 2022 Pages: 531 - 545
Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants Akshaya Srikanth BhagavathulaBenjamin WoolfWubshet Tesfaye Review 18 January 2022 Pages: 547 - 555
Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study Vladimír NosáľAndrea PetrovičováMarián Mokáň Pharmacodynamics 22 January 2022 Pages: 557 - 564
A genetic-based population PK/PD modeling of methadone in Chinese opiate dependence patients Dong GuoZhirong TanHong Yang Pharmacogenetics 11 January 2022 Pages: 565 - 578
Man vs. machine: comparison of pharmacogenetic expert counselling with a clinical medication support system in a study with 200 genotyped patients Sally H. PreissnerPaolo MarchettiRobert Preissner Pharmacogenetics Open access 27 December 2021 Pages: 579 - 587
Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide Jiangchuan LongYongjian LiuDongfang Liu Pharmacogenetics 15 January 2022 Pages: 589 - 596
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib Jeffry AdiwidjajaAlan V. BoddyAndrew J. McLachlan Pharmacokinetics and Disposition 20 January 2022 Pages: 597 - 611
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant Hideyuki HibinoNaomi SakiyamaHisakazu Ohtani Pharmacokinetics and Disposition 17 January 2022 Pages: 613 - 621
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis Abdulrhman Al RowilyZahraa JalalVibhu Paudyal Pharmacoepidemiology and Prescription Open access 22 December 2021 Pages: 623 - 645
Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease Mengshi YiXi FengZheyu Chen Pharmacoepidemiology and Prescription 15 January 2022 Pages: 647 - 656
Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018 Ina-Maria Rückert-EhebergMichael NoldeSebastian-Edgar Baumeister Pharmacoepidemiology and Prescription Open access 08 December 2021 Pages: 657 - 667
Drug utilisation in neonatal units in England and Wales: a national cohort study Asma Al-TurkaitLisa SzatkowskiShalini Ojha Pharmacoepidemiology and Prescription Open access 13 January 2022 Pages: 669 - 677
Evaluation of two European risk models for predicting medication harm in an Australian patient cohort Nazanin FalconerMichael BarrasNeil Cottrell Pharmacoepidemiology and Prescription 18 January 2022 Pages: 679 - 686
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entity Thierry TrenqueElise LepoixBrahim Azzouz Pharmacoepidemiology and Prescription 06 January 2022 Pages: 687 - 690
European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology Andrej BelančićCarla Sans-Polathe EACPT Young Clinical Pharmacologists Working Group Special Article 17 January 2022 Pages: 691 - 694
Updated network meta-analysis assessing the relative efficacy of 13 GLP-1 RA and SGLT2 inhibitor interventions on cardiorenal and mortality outcomes in type 2 diabetes Mei QiuWei WeiShu-Yan Liu Letter to the Editor 03 December 2021 Pages: 695 - 697
Elevation of alkaline phosphatase and long-term drug therapy for cystic fibrosis Quentin DelmezVincent HaufroidPhilippe Hantson Letter to the Editor 15 January 2022 Pages: 699 - 701
Severe CNS depression with duloxetine, ciprofloxacin and CYP2D6 deficiency—role and recognition of drug-drug-gene interactions Matthias HoffmannStefan RussmannDavid F. Niedrig Letter to the Editor 17 January 2022 Pages: 703 - 705